Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ferroptosis is a regulated, iron-dependent form of cell death characterized by the accumulation of lipid peroxides and reactive oxygen species (ROS). Inhibitors targeting the ferroptosis pathway are molecules or drugs that prevent this specific type of cell death, offering therapeutic potential in diseases where ferroptosis contributes to pathology, such as neurodegeneration, ischemic injury, and certain cancers.
Enhancing antioxidant defenses via upregulation or stabilization of GPX4/GSH system; Scavenging free radicals directly; Chelating intracellular iron to limit ROS production; Supporting alternative antioxidative systems such as FSP1-CoQ10-NAD(P)H axis
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ferroptosis Pathway (Inhibitor).